Drug Development
Using Artificial Intelligence-based Methods to Address the Placebo Response in Clinical Trials
by Erica A. Smith, PhD; William P. Horan, PhD; Dominique
January 1, 2022
No Comments
by Erica A. Smith, PhD; William P. Horan, PhD; Dominique
A message from the editor Dear Colleagues: Welcome to the
A message from the editor Dear Colleagues: Welcome to the
by Robert E. Litman, MD; Peter Sorantin, PhD; and Elia
A message from the editor: Dear Colleagues: Welcome to the
by Mark E. Whitlock, PhD; Philip W. Woodward, MPhil; and
A message from the editor: Dear Colleagues: Welcome to the
Dear Colleagues: Thirty years ago, the Positive and Negative Syndrome
by Seth C. Hopkins, PhD; Ajay Ogirala, PhD, Antony Loebel,
by Mark G. A. Opler, PhD, MPH; Christian Yavorsky, PhD; and
